Literature DB >> 20526282

Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.

Margaret E Harley1, Lindsey A Allan, Helen S Sanderson, Paul R Clarke.   

Abstract

The balance between cell cycle progression and apoptosis is important for both surveillance against genomic defects and responses to drugs that arrest the cell cycle. In this report, we show that the level of the human anti-apoptotic protein Mcl-1 is regulated during the cell cycle and peaks at mitosis. Mcl-1 is phosphorylated at two sites in mitosis, Ser64 and Thr92. Phosphorylation of Thr92 by cyclin-dependent kinase 1 (CDK1)-cyclin B1 initiates degradation of Mcl-1 in cells arrested in mitosis by microtubule poisons. Mcl-1 destruction during mitotic arrest requires proteasome activity and is dependent on Cdc20/Fizzy, which mediates recognition of mitotic substrates by the anaphase-promoting complex/cyclosome (APC/C) E3 ubiquitin ligase. Stabilisation of Mcl-1 during mitotic arrest by mutation of either Thr92 or a D-box destruction motif inhibits the induction of apoptosis by microtubule poisons. Thus, phosphorylation of Mcl-1 by CDK1-cyclin B1 and its APC/C(Cdc20)-mediated destruction initiates apoptosis if a cell fails to resolve mitosis. Regulation of apoptosis, therefore, is linked intrinsically to progression through mitosis and is governed by a temporal mechanism that distinguishes between normal mitosis and prolonged mitotic arrest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20526282      PMCID: PMC2910263          DOI: 10.1038/emboj.2010.112

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

Review 1.  Splitting the chromosome: cutting the ties that bind sister chromatids.

Authors:  K Nasmyth; J M Peters; F Uhlmann
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

Review 2.  Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint.

Authors:  Conly L Rieder; Helder Maiato
Journal:  Dev Cell       Date:  2004-11       Impact factor: 12.270

Review 3.  Mitosis: a matter of getting rid of the right protein at the right time.

Authors:  Jonathon Pines
Journal:  Trends Cell Biol       Date:  2005-12-05       Impact factor: 20.808

4.  Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.

Authors:  Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

5.  Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.

Authors:  Ulrich Maurer; Céline Charvet; Allan S Wagman; Emmanuel Dejardin; Douglas R Green
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

Review 6.  Cell-cycle control in the face of damage--a matter of life or death.

Authors:  Paul R Clarke; Lindsey A Allan
Journal:  Trends Cell Biol       Date:  2009-01-23       Impact factor: 20.808

7.  Phosphate-binding tag, a new tool to visualize phosphorylated proteins.

Authors:  Eiji Kinoshita; Emiko Kinoshita-Kikuta; Kei Takiyama; Tohru Koike
Journal:  Mol Cell Proteomics       Date:  2005-12-11       Impact factor: 5.911

8.  Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C.

Authors:  Michelle J Hayes; Yuu Kimata; Samantha L Wattam; Catherine Lindon; Guojie Mao; Hiroyuki Yamano; Andrew M Fry
Journal:  Nat Cell Biol       Date:  2006-04-30       Impact factor: 28.824

9.  Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction.

Authors:  Lihua Du; Christopher S Lyle; Timothy C Chambers
Journal:  Oncogene       Date:  2005-01-06       Impact factor: 9.867

10.  Differential requirement for caspase 9 in apoptotic pathways in vivo.

Authors:  R Hakem; A Hakem; G S Duncan; J T Henderson; M Woo; M S Soengas; A Elia; J L de la Pompa; D Kagi; W Khoo; J Potter; R Yoshida; S A Kaufman; S W Lowe; J M Penninger; T W Mak
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

View more
  167 in total

1.  Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.

Authors:  Takumi Kawabata; Susumu Tanimura; Kohei Asai; Ryohei Kawasaki; Yumi Matsumaru; Michiaki Kohno
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Identification of a novel Mcl-1 protein binding motif.

Authors:  William J Placzek; Mattia Sturlese; Bainan Wu; Jason F Cellitti; Jun Wei; Maurizio Pellecchia
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

3.  Stalling in mitosis and releasing the apoptotic brake.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  EMBO J       Date:  2010-07-21       Impact factor: 11.598

4.  Nonparametric Bayesian evaluation of differential protein quantification.

Authors:  Oliver Serang; A Ertugrul Cansizoglu; Lukas Käll; Hanno Steen; Judith A Steen
Journal:  J Proteome Res       Date:  2013-09-11       Impact factor: 4.466

5.  BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy.

Authors:  Dominik Schnerch; Andrea Schmidts; Marie Follo; Josefina Udi; Julia Felthaus; Dietmar Pfeifer; Monika Engelhardt; Ralph Wäsch
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

Review 6.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

Review 7.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

8.  Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells.

Authors:  Sylvia S Gayle; Jennifer M Sahni; Bryan M Webb; Kristen L Weber-Bonk; Melyssa S Shively; Raffaella Spina; Eli E Bar; Mathew K Summers; Ruth A Keri
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

9.  Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.

Authors:  Shanna K Nifoussi; Nora R Ratcliffe; Deborah L Ornstein; Gary Kasof; Stefan Strack; Ruth W Craig
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

10.  Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.

Authors:  Roger S Jackson; William Placzek; Ana Fernandez; Shabnam Ziaee; Chia-Yi Chu; Jun Wei; John Stebbins; Shinichi Kitada; Gloria Fritz; John C Reed; Leland W Chung; Maurizio Pellecchia; Neil A Bhowmick
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.